3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Congenital Abnormalities
2
Carcinoma, Renal Cell
2
Uveal Melanoma
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms, Neuroepithelial
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Interventions
fludarabine phosphate
12
Mycophenolic Acid
12
Cyclophosphamide
11
Whole-Body Irradiation
10
Cyclosporine
10
Cord Blood Stem Cell Transplantation
9
Peripheral Blood Stem Cell Transplantation
7
Busulfan
6
Tacrolimus
5
Radiotherapy
5
fludarabine
4
Antilymphocyte Serum
4
Thiotepa
3
Methotrexate
3
Melphalan
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Etoposide
3
Cyclosporins
3
sargramostim
2
merphos
2
Methylprednisolone
2
Decitabine
2
Cytarabine
2
vatalanib
1
poly ICLC
1
lintuzumab
1
entinostat
1
Vorinostat
1
Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Anemia, Refractory
×
Immunologic Techniques
×
Clear all
No trials found.